Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dihydro-5-azacytidine (DHAC) is a nucleoside analog that interrupts DNA methylation by integrating into DNA. It also exhibits notable antitumor properties.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 1,520.00 |
Description | Dihydro-5-azacytidine (DHAC) is a nucleoside analog that interrupts DNA methylation by integrating into DNA. It also exhibits notable antitumor properties. |
In vitro | Methylation research reveals that administering an LD 10 dose of [3H]DHAC induces 25.06% DNA hypomethylation in L1210/0 cells and 46.32% in L1210/dCK(-) deoxycytidine kinase mutant cells, relative to their controls[2]. Furthermore, Dihydro-5-azacytidine (DHAC) competes with cytidine triphosphate for RNA integration, resulting in ribosomal breakdown and impaired protein synthesis[1]. |
In vivo | In tumor-bearing mice (injected with L1210/0 cells), receiving an LD 10 dose of Dihydro-5-azacytidine (DHAC; 1500 mg/kg) results in a peak plasma concentration of 317 μM, followed by biexponential elimination characterized by a half-life (t 1/2) of 1.03 hours (α phase) and 5 hours (β phase)[2]. |
Synonyms | DHAC, NSC264880, Dihydro-5-azacytidine |
Molecular Weight | 246.223 |
Formula | C8H14N4O5 |
CAS No. | 62488-57-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dihydro-5-azacytidine 62488-57-7 NSC-264880 DHAC Dihydro5azacytidine NSC264880 NSC 264880 Dihydro 5 azacytidine inhibitor inhibit